James Schaub - Net Worth and Insider Trading
James Schaub Net Worth
The estimated net worth of James Schaub is at least $270 dollars as of 2024-06-06. James Schaub is the EVP and COO of RVL Pharmaceuticals PLC and owns about 540,020 shares of RVL Pharmaceuticals PLC (RVLPQ) stock worth over $270. Details can be seen in James Schaub's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Schaub has not made any transactions after 2022-08-08 and currently still holds the listed stock(s).
Transaction Summary of James Schaub
James Schaub Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Schaub owns 1 companies in total, including RVL Pharmaceuticals PLC (RVLPQ) .
Click here to see the complete history of James Schaub’s form 4 insider trades.
Insider Ownership Summary of James Schaub
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVLPQ | RVL Pharmaceuticals PLC | 2022-08-08 | EVP and COO |
James Schaub Latest Holdings Summary
James Schaub currently owns a total of 1 stock. James Schaub owns 540,020 shares of RVL Pharmaceuticals PLC (RVLPQ) as of August 8, 2022, with a value of $270.
Latest Holdings of James Schaub
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVLPQ | RVL Pharmaceuticals PLC | 2022-08-08 | 540,020 | 0.00 | 270 |
Holding Weightings of James Schaub
James Schaub Form 4 Trading Tracker
According to the SEC Form 4 filings, James Schaub has made a total of 2 transactions in RVL Pharmaceuticals PLC (RVLPQ) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in RVL Pharmaceuticals PLC is the acquisition of 150,000 shares on August 8, 2022, which cost James Schaub around $232,500.
Insider Trading History of James Schaub
- 1
James Schaub Trading Performance
GuruFocus tracks the stock performance after each of James Schaub's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Schaub is 60.38%. GuruFocus also compares James Schaub's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Schaub within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Schaub's insider trading performs compared to the benchmark.
Performance of James Schaub
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 35.38 | | | | | |
| Relative Return to S&P 500(%) | 37.05 | | | | | |
James Schaub Ownership Network
James Schaub Owned Company Details
What does RVL Pharmaceuticals PLC do?
Who are the key executives at RVL Pharmaceuticals PLC?
James Schaub is the EVP and COO of RVL Pharmaceuticals PLC. Other key executives at RVL Pharmaceuticals PLC include 10 percent owner Foundation Harsaul , 10 percent owner Altchem Ltd , and 10 percent owner Athyrium Opportunities Associates Iv Co-invest Llc .
RVL Pharmaceuticals PLC (RVLPQ) Insider Trades Summary
Over the past 18 months, James Schaub made no insider transaction in RVL Pharmaceuticals PLC (RVLPQ). Other recent insider transactions involving RVL Pharmaceuticals PLC (RVLPQ) include a net sale of 17,544,196 shares made by Foundation Harsaul , and a net sale of 17,544,196 shares made by Altchem Ltd .
In summary, during the past 3 months, insiders sold 0 shares of RVL Pharmaceuticals PLC (RVLPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35,088,392 shares of RVL Pharmaceuticals PLC (RVLPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,088,392 shares.
RVL Pharmaceuticals PLC (RVLPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
RVL Pharmaceuticals PLC Insider Transactions
James Schaub Mailing Address
Above is the net worth, insider trading, and ownership report for James Schaub. You might contact James Schaub via mailing address: 400 Crossing Boulevard, C/o Osmotica Pharmaceuticals Plc, Bridgewater Nj 08807.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
